Navigation Links
Eurotech Wins 1.5M USD Contract To Supply Embedded Computers For Medical Application
Date:6/3/2010

COLUMBIA, Md., June 3 /PRNewswire/ -- Eurotech, a leading supplier of embedded technologies, products, and systems, today announces a 1.5 Million USD contract to supply embedded computers to a medical original equipment manufacturer (OEM) that specializes in diagnostics and information technology solutions. The six-month contract will allow the customer to meet market demand for chemistry analyzers with the Eurotech Sphere II single board computer.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090226/PH75840LOGO )

The customer chose Eurotech to upgrade its existing products to a newer, high-value single board computer extending the lifecycle of these products using this ARM technology.  Used to test for diseases in just minutes, these products connect to a laboratory information management system that collects all results into an electronic medical record.

The Sphere II is a full-featured single board computer with CAN Bus, robust I/O, storage, and versatility features. Based on the Cirrus EP9315 ARM9 RISC-based processor, Sphere II provides the platform for a high performance system with very low power consumption. It features rich graphics to XGA with comprehensive on-board I/O including three serial ports, Ethernet 10/100baseT, USB host and an AC97 stereo codec, all in a small form factor that can operate without fans or heatsinks.

"With the breadth of Sphere II features and performance, medical OEMS can quickly capitalize on their product development efforts to earn additional revenue from proven product lines," explained Greg Nicoloso, Chief Executive Officer of Eurotech Inc. "Eurotech offers multiple hardware solutions, including both ARM and Intel Atom embedded computers, as well as software options and customization to facilitate our customers' success."

About Eurotech

Eurotech is a publicly listed global company (ETH.MI) that integrates hardware, software, services, and expertise to deliver embedded computing platforms and sub-systems to leading OEMs, system integrators and enterprise customers for successful and efficient deployment of their products and services. Drawing on concepts of minimalist computing, Eurotech lowers power draw, minimizes physical size and reduces coding complexity to bring sensors, embedded platforms, sub-systems, ready-to-use devices and high performance computers to market, specializing in healthcare, security, defense, transportation, industrial and energy segments. By combining domain expertise in wireless connectivity as well as communications protocols, Eurotech architects integrated solutions that simplify data capture, processing and transfer over unified communications networks. Our customers rely on us to simplify their access to state-of-art embedded technologies so they can focus on their core competencies. Learn more about Eurotech at www.eurotech.com.


'/>"/>
SOURCE Eurotech
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Eurotech Unveils New Diabetes Care Management Solution
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
4. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
5. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
6. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
7. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
8. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
9. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
10. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):